Dynamics of SARS-CoV-2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine

Dynamics of SARS-CoV-2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine

We evaluated the longitudinal dynamics of antibody response to the SARS-CoV-2 vaccine CoronaVac and the effect of a booster dose of BNT162b2 vaccine. We found a robust antibody response after the second dose of CoronaVac that wanes over time. The response was recovered by BNT162b2, which boosted an...

Full description

Bibliographic Details
Main Authors: Marcela Helena Gambim Fonseca, Ana Carolina Matias Dinelly Pinto, Maria Francilene Souza Silva, Amanda Campelo Lima de Melo, Germana Silva Vasconcelos, Eduardo Ruback dos Santos, Fernanda Montenegro de Carvalho Araújo, Luiz Odorico Monteiro de Andrade
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2022-06-01
Series:Emerging Infectious Diseases
Subjects:
COVID-19
coronavirus disease
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
viruses
respiratory infections
Online Access:https://wwwnc.cdc.gov/eid/article/28/6/22-0061_article

Similar Items

Similar Items